Vol 16, No 5 (October 31, 2025): Journal of Gastrointestinal Oncology

Original Article

Oral microbial alterations by smoking and metabolic factors in esophageal squamous cell carcinoma
Kyoungwon Jung, Minjae Joo, Kwangwoo Nam, Joon Hyun Cho, Young Sin Cho, Seungyoon Nam, Su Youn Nam
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:1796-1811
.
Impact of maintenance therapy with fluoropyrimidines in advanced esophageal-gastric adenocarcinoma: a retrospective study in Mexican population
Abdel Karim Dip Borunda, Alberto Pimentel Rentería, Rafael Medrano Guzmán, Lizbeth Enríquez Román, Ana Elena Martin Aguilar, Rocío Grajales Álvarez, María Teresa De Jesús Cervantes Diaz
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:1812-1819
.
Deciphering the immunometabolic axis: a mendelian randomization study of a causal cascade network from immune cell phenotypes to metabolites in esophageal cancer
Daying Gui, Jingxun Wu, Yi Feng, Simin Lu, Siyu Guo, Kai Wu, Zhengyang Yan, Hehui Wang, Hejing Sun, Shubin Wang, Wenhua Liang, Xuan Wu
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:1820-1836
.
Expression and clinical significance of ERBB4 in gastric cancer
Xiaofeng Zhou, Siyu Zhao, Lin Zheng, Xiaoxuan Ye, Weicheng Li, Liang Zhang, Yuyue Zhang, Shuling Liu, Ye Hong, Renyao Wu, Fan Bu, Guangxian You, Ruizhi Ye, Fengming Zhang, Can Hu, Lili Wu, Rongbiao Ying
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:1837-1849
.
Predictive factors for successful conversion therapy in gastric cancer with peritoneal metastasis: a case-control study
Zhongqiang Zheng, Xuanzi Sun
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:1850-1861
.
Integrated bioinformatic and machine learning analysis identifies MCM7 and ADAM17 as potential biomarkers for early stage gastric cancer
Fei Li, Gang Liu, Jin Wang, Zhizhai Luo
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:1862-1877
.
Prognostic factors for overall survival in patients with early gastric cancer: a retrospective cohort study based on SEER database
Peng Song, Yongjie Zhao, Wencong Tian, Yanhong Liu, Chuntao Wang, Jia Zhao, Lei Cao
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:1878-1889
.
Trends and incidence of stomach cancer in middle-aged and elderly populations: a global burden of disease analysis
Yubao Tang, Danyang Wang, Zhicheng Xu, Hanyu Wang, Haixia Tian, Weijing Wang, Dong Hua
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:1890-1901
.
Stemness-based gastric cancer classification by machine learning for precision diagnosis and treatment of gastric cancer
Shixin Zhou, Chenyu Tian, Tao Zhu, Hao Chen, Changxin Chen, Quan Jiang, Fenglin Liu
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:1902-1923
.
Global, regional, and national burden of gastrointestinal cancers in early onset and young women, 1990–2021: analysis of data from the Global Burden of Disease study 2021
Yinghong Li, Mingjie Tang, Shiwei Li, Ziwen Li, Zhaoming Chen, Jiqin Tang, Peng Shu, Weixing Shen
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:1924-1943
.
A promising model for prediction of chemotherapeutic sensitivity in gastrointestinal cancers using patient-derived malignant ascites organoids
Xiaofu Yu, Yulu Fang, Yifan Zhao, Jinping Xiao, Si’an Chen, Zhong Shi
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:1944-1961
.
Disparities in gastrointestinal cancer trials recruitment: analyzing demographic gaps compared to the real-world
Wissam Ghusn, Elisia Maalouf, Noura Jawhar, Yara Salameh, Marita Salame, Andrew Takchi, Lynn Kobeissi, Tamara Kadi, Rudy Mrad, Sara F. Haddad, Aline Charabaty, Sandra Quezada
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:1962-1970
.
Preoperative prediction of tumor budding in colorectal cancer based on quantitative parameters of dual-layer detector spectral computed tomography: a preliminary study
Pengqiang Li, Nianjun Liu, Yanfei Wang, Jinhui Lan, Huling Ren, Jing Wang, Yu Dou
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:1971-1984
.
Prognostic and safety analysis of capecitabine monotherapy versus CapeOx (capecitabine plus oxaliplatin) in elderly patients with high-risk stage II and stage III MRD-negative colorectal cancer
Jiawei Zhai, Rongjian Tan, Wenting Ou, Zhenhao Quan, Lijun Sun, Xianjin Huang, Jiayuan Wu, Caijin Zhou
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:1985-2000
.
Clinical outcomes of third-line chemotherapy prior to best supportive care in patients with stage IV colorectal cancer: a single-center study from Japan
Shigeo Higami, Masaya Mukai, Kyoko Kishima, Shigeya Takeo, Lin Fung Chan, Tomoki Nakamura, Hideki Izumi, Kazutake Okada, Souichirou Yamamoto, Kazuhito Nabeshima, Junichi Kaneko, Hiroyasu Makuuchi
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2001-2012
.
Integrating nutritional and immune-inflammation-based index predicts disease-free survival of colorectal cancer patients undergoing radical surgery
Lina Xu, Lei Huang, Jun Lv, Chunxiang Liu, Wenhu Gui, Yuan Liu
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2013-2025
.
ISM2 as a prognostic biomarker and mediator of immune infiltration in colorectal cancer: evidence from bioinformatics and experimental analysis
Wen-Hui Qiang, Ran Ji, Xiao-Yun Yan, Jia-Qi Ye, Ying Jiang, Hai-Xiao Chen, Dong-Sheng Zhao, Qing Zhang
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2026-2043
.
Molecular and clinical registry of Chilean patients diagnosed with BRAF-mutated colorectal cancer
Benjamín García-Bloj, Tomás de Mayo Glaser, Fernando Sigler Chávez, Matías Muñoz-Medel, Nicolas Cueto, Felipe Pinto, Paola Aravena, Ignacio N. Retamal, Fernán Gómez-Valenzuela, Ian Silva, Javiera Garrido, Ignacio Corvalán, María E. Avendaño, Cristopher San Martin Abello, Andrea C. Sabioncello H, Marcelo Garrido Villanueva, José M. Erpel, Jenny F. Henríquez, Juan A. Godoy, Marcelo Garrido
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2044-2057
.
Evaluating the cross-reactivity of a stool methylated syndecan-2 (meSDC2) test in colorectal cancer detection
Seung Wook Hong, Tae Jeong Oh, Sung Wook Hwang, Sang Hyoung Park, Byong Duk Ye, Jeong-Sik Byeon, Seung-Jae Myung, Suk-Kyun Yang, Sungwhan An, Dong-Hoon Yang
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2058-2066
.
Prognostic nomogram for colorectal cancer liver metastasis treated with tumor resection and chemotherapy based on SEER database
Qiao Zhang, Xuezhi Zhou, Sai Cheng, Xinjun Wu, Dezhong Zhang, Shaohui Zhu
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2067-2083
.
Body mass index-defined overweight (but not obese) correlates with better postoperative prognosis in colorectal cancer
Xiujie Shu, Ziwei Wang, Xiaoyan Liang
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2084-2100
.
Study on ensemble model with weight allocation based on improved dung beetle optimization algorithm for screening colorectal cancer using laboratory test indicators
Zhou Yu, Jianping Wang, Ping Li, Wanxiu Xu
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2101-2115
.
Construction of conditional survival nomograms for metastatic early onset colon cancer patients
Jue Luo, Lei Zhao, Shuyi Zhang, Renjie Wang, Y. Nancy You, Jaganmurugan Ramamurthy, Jie Ju, Tingting Shi, Liwen Bu, Yan Ding
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2116-2126
.
Bioinformatics analysis of TCGA data identifies a taurine metabolism-related subtype classification for predicting prognosis in colon adenocarcinoma
Xinping Sun, Juhua Dai, Bozhi Lin, Yujing Sun, Liyuan Chen
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2127-2137
.
Ethnic and socioeconomic disparities in survival outcomes among patients under 65 years with intrahepatic cholangiocarcinoma: a SEER analysis
Adit Dharia, Lianchun Xiao, Janak Abraham, Fen Saj, Madhulika Eluri, Zishuo Ian Hu, Sunyoung S. Lee, Manal Hassan, Salman Muddassir, Milind M. Javle
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2138-2145
.
Safety and efficacy of liver-directed radiotherapy after chemoimmunotherapy for advanced cholangiocarcinoma: an early report from a large tertiary cancer center
Abdulmoiz Asif, Abdulmoid Asif, Michael K. Rooney, Enoch Chang, Felicity Namayanja, Kimana Quentin, Sunyoung Lee, Ian Hu, Vincent Bernard, Prajnan Das, Emma B. Holiday, Sonal Noticewala, Grace L. Smith, Albert C. Koong, Ethan B. Ludmir, Milind Javle, Lianchun Xiao, Eugene J. Koay
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2146-2157
.
Global, regional, and national burden of liver cancer attributable to hepatitis B virus among middle-aged and older adults from 1990 to 2021 and projections to 2035: results of the Global Burden of Disease Study 2021
Linghu Wang, Yue Pu, Wenkai Wu, Xiaochan Xu, Qi Zhang
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2158-2175
.
Comprehensive bioinformatic analysis reveals sorafenib response-related prognostic signature in hepatocellular carcinoma
Yuanyu Zhao, Junfeng Dong, Hanxiang Zhong, Liangxi Peng, Liang Wu, Meicen Yu, Guoshan Ding, Wenyuan Guo
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2176-2192
.
Quantitative assessment of multi-phase contrast-enhanced CT features in hepatic epithelioid hemangioendothelioma
He Chen, Wenying Zhou, Jie Lin, Yanyan Xu, Sheng Li
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2193-2202
.
Financial toxicity in patients with newly diagnosed hepatocellular carcinoma: a cross-sectional study
Seohyuk Lee, Esteban Garita, Santiago Sucre, Juan Jose Juarez, Mary Linton B. Peters, Andrea J. Bullock
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2203-2212
.
Relationship between spontaneous rupture of hepatocellular carcinoma (SRHCC) and long-term survival after anatomic liver resection
Yihuan Xu, Zian Zhu, Ziyan Yu, Xiangrui Zhang, Jinkai Jiang, Qingqing Hu, Tongyao Gao, Jinmin Zhang, Zhenguang Wang, Hui Liu
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2213-2224
.
YTHDF1 regulates YTHDF2 stability via m6A-dependent mechanisms in hepatocellular carcinoma: insights from in vitro, in vivo, and multi-cohort clinical studies
Yue-Fan Wang, Zeng-Han Wang, Zhi-Chao Zhang, Jian Tan, Zhi-Xuan Li, Hao-Zan Yin, Xian-Jie Piao, Zhi-Hui Dai, Chen-Yang Mu, Si-Jie Wang, Qian-Jia Liu, Jia-Cheng Zhang, Fu-Chen Liu, Wei Dong, Zheng-Guang Wang, Sheng-Xian Yuan, Fu Yang, Hui Liu
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2225-2244
.
CYSTM1 is a potential diagnostic and prognostic biomarker and correlated with immune infiltrates in hepatocellular carcinoma
Ning Zhang, Junling Zhen, Xiangnan Kong
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2245-2261
.
Prognostic value of a simplified score based on routine parameters in patients with hepatocellular carcinoma treated with systemic therapies: a retrospective cohort study
Leonardo G. Da Fonseca, Thamires Haick Martins da Silveira, Victor Junji Yamamoto, Marina Acevedo Zarzar de Melo, Lucas Takeshi Ikeoka, Pedro Henrique Shimiti Hashizume, Jorge Sabbaga
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2262-2273
.
ZNF529 up-regulation speeds up progression and induces tyrosine kinase inhibitor resistance in hepatocellular carcinoma
Kai Qin, Sheng-Sheng Zhou, Jian-Di Li, Di-Yuan Qin, Da-Tong Zeng, Wan-Ying Huang, Zhi-Guang Huang, Gao-Peng Yao, Yu-Zhen Chen, Bin-Tong Yin, Fu-Xi Li, Lei Wang, Gang Chen, Rong-Quan He
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2274-2288
.
Development and validation of a GP73-based predictive model for the diagnosis of early-stage hepatocellular carcinoma
Shan Ji, Yumeng Liu, Yuhua Li, Jiaying Zhang, Tongzeng Li, Danlei Mou, Lianchun Liang, Yingmei Feng
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2289-2301
.
Construction of a predictive model for gemcitabine combined with cisplatin resistance in intrahepatic cholangiocarcinoma based on multidimensional inflammatory indices
Xiaofeng Zhou, Yu Shi
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2302-2313
.
STRIP2 promotes hepatocellular carcinoma progression and immune evasion: a potential prognostic biomarker and therapeutic target
Wuhan Yang, Yaowen Chen, Hao Guo, Jiaqi Zhang, Shubin Wang, Li Peng
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2314-2335
.
A combination of MRI diffusion-derived vessel density (DDVD) and slow diffusion coefficient (SDC) can reliably diagnose liver hemangioma: a testing of three centers’ data
Gen-Wen Hu, Cai-Ying Li, Gong-Hao Ling, Cun-Jing Zheng, Michael S. Y. Zhu, Akmal Sabarudin, Xiao-Hui Duan, Xin-Ming Li, Jun Shen, Yì Xiáng J. Wáng
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2336-2356
.
The SNHG3/miR-148a-3p axis-mediated high expression of DNMT1 is correlated with poor prognosis and tumor immune infiltration in hepatocellular carcinoma
Ninghua Yao, Ganling Qu, Yumeng Shi, Huajie Miao, Gaojia Sun, Jie Sun, Wenjie Zheng, Hongyu Zhao
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2357-2376
.
Effects of current smoking on treatment outcomes in metastatic and locally advanced pancreatic carcinoma: a retrospective cohort study using the international PURPLE pancreas cancer registry
Faisal Hayat, Simon Chiu, Ashleigh Stuart, Belinda Lee, Peter Gibbs, Julie Johns, Benjamin Thomson, Rachel Wong, Margaret Lee, Mehrdad Nikfarjam, Jeremy Shapiro, Sue-Anne McLachlan, Cheng Ean Chee, Robert Zielinski, David Tai, Sharon Pattison, Susan Caird, Zee Wan Wong, Prasad Cooray, Craig Underhill, Amitesh Roy, Adnan Nagrial, David Goldstein, Chris Paul, Fiona Day
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2377-2387
.
Identification of key genes in pancreatic ductal adenocarcinoma with biologically informed deep neural network
Ru Gao, Ruichen Li, Yichen Xing, Qihao Wang, Xiuliang Cui, Jingjing Fang, Lijie Zhang, Bin Song
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2388-2401
.

Review Article

Recent advancements in systemic therapy for biliary tract cancers: a literature review
Muhammad Masroor Hussain, Sana Qammar, Ju-Mei Wang, Ao-Qiang Zhai, Fu-Yu Li, Hai-Jie Hu
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2402-2429
.

Study Protocol

Adebrelimab combined with anlotinib plus hepatic arterial infusion chemotherapy or intravenous chemotherapy for first-line treatment of advanced biliary tract cancer: protocol for a randomized open-label clinical study
Jie Zeng, Jie Liu, Fuchao Ma, Lihua Yang, Yanfeng Jiang, Ning Mo, Cuizhen Liu, Jing Tang, Xiaoqiang Fang, Zhiming Zeng, Jie Ma
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2430-2440
.

Surgical Technique

Clinical application of indocyanine green fluorescence imaging technology in laparoscopic rectal cancer surgery
Baokun Li, Chaoxi Zhou, Jiaxu Han, Jun Feng, Zesong Meng, Xuhua Hu, Fei Yang, Ganlin Guo, Yaran An, Bin Yu, Guiying Wang
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2441-2451
.
Fluorescence-guided laparoscopic-assisted transabdominal intersphincteric resection for ultralow rectal cancer: report of a surgical technique
Shaojun Liu, Lei Hu, Zhiqiang Zhu, Xubing Zhang
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2452-2460
.
Application of modified laparoscopic stomach-partitioning gastrojejunostomy for stage IV gastric cancer with gastric outlet obstruction
Haikuo Wang, Xinxin Shao, Peng Wang, Haitao Hu, Yiming Lu, Yujun Jiang, Wangyao Li, Quan Xu, Yantao Tian
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2461-2471
.
Fluorescence-guided laparoscopic resection of liver segment 4 plus the right anterior ventral section for hepatocellular carcinoma adjacent to the left hepatic pedicle and middle hepatic vein: a case report
Zian Huang, Yongcong Yan, Yajin Chen, Gregor Alexander Stavrou, Zhiyu Xiao, Zhenyu Zhou
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2472-2484
.

Case Report

Atypical abdominal pain: uncovering malignant peritoneal mesothelioma in suspected Crohn’s disease: a case report
Catherine Loehr, Lara Boudreaux, Ann Porter Uhlhorn, Nisha Loganantharaj
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2485-2491
.
Extramedullary metastasis of the hilar bile duct in multiple myeloma: a case report and literature review
Fei Liu, Wei Li, Wanfeng Wu, Buwei Teng, Wenlei Li, Kai Li, Xiangcheng Li
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2492-2498
.

Editorial

Investigating survival patterns in pancreatic adenocarcinoma over two decades after introducing FOLFIRINOX
Jessica Döbereiner, Jörg Kleeff, Artur Rebelo
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2499-2501
.
Spotlight on AMIGO2 as a novel prognostic indicator in pancreatic cancer
Alessandro Nasti, Duncan Ayers, Akihiro Seki
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2502-2505
.
D3 lymph node dissection in right-sided colon cancer: routine requirement or selective application?
Valentin Butnari, Phrmpreet Mann, Timothy Jones, Harpreet Kaur Sekhon Inderjit Singh, Nikhil Pawa, Nirooshun Rajendran, Richard Boulton, Joseph Huang, Sandeep Kaul
Journal of Gastrointestinal Oncology  
2025;
16
(5)
:2506-2514
.